Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation-A single institution experience.

Leuk Res Rep · 2022 · PMC9557030 · PMID 36247071

Europe PMC DOI

hedged sentence

0.0198

closest p · 0.4× alpha

0.0198

boldest claim

The sentences

showed a trendp=0.0198actually significant

Achievement of CMR pre-HSCT showed a trend towards improved 2-year EFS (p=0.0198) but did not significantly change 2-year OS (p = 1).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.